Symbiont Stock

Symbiont has developed the market-leading platform for institutional applications of blockchain technology.

Sign up today and learn more about Symbiont Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Founded

2015

Notable Investors

Wicklow Capital

Headquarters

New York NY, US

Total Funding

$15.4M

About Symbiont Stock

Symbiont has developed the market-leading platform for institutional applications of blockchain technology. Symbiont smart contracts enable complex instruments to live their entire lifecycle on a truly decentralized, enterprise blockchain network with end-to-end privacy. Financial institutions and governments are working with Symbiont to develop new business lines, increase transparency, reduce risk, and save costs. Industry leaders such as Vanguard and the State of Delaware have chosen to partner with Symbiont. Headquartered in New York City, Symbiont is a financial technology company founded by a team of experts in capital markets and blockchain technology.

Investors

Funding History

June 2014$375K
May 2017$15.0M

Management

Founder

Evan Wagner

Founder & CEO

Mark Smith

Founder & Chief Technology Officer

Adam Krellenstein

Chairman & President

Caitlin Long

Press

businesswire - May, 9 2023

Symbiont.io Pursues Sale of Assets

bankinnovation - Jun, 30 2020

Vanguard taps blockchain fintech for FX

cryptocoinsnews - Jan, 14 2016

Are Smart Contracts The Future Of Blockchain?

efinancialnews - Sep, 30 2015

Meet the new kids on the blockchain

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo